Observational studyThe oncologist2025

Real-world effectiveness of palbociclib plus endocrine therapy in HR+/HER2- advanced breast cancer: final results from the POLARIS trial.

Debu Tripathy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.